Payapwattanawong, S., Lal, J., Xu, Y., Lin, K., Osterlund, E., Yeung, C., Martin, B., Aziz, K., Alfaro, K., Maddalena, G., Vetere, G., Dasari, A., Parseghian, C., Willis, J., Shen, J. P. Y., Overman, M. J., Raghav, K. P. S., Morris, V. K., Rai, K., Kopetz, S. (2026). Use of KMT2 family mutations to define a distinct epithelial-high, stromal-depleted, and interferon-active gene expression state in colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3671